Nirsevimab may help prevent severe respiratory illnesses beyond RSV in infants, young kids
In addition to reducing respiratory syncytial virus (RSV)–related hospitalizations and emergency department (ED) visits, nirsevimab (Beyfortus) may also reduce these ...





